mTOR
Term · Oncology and biomedicine · MLC-T-ONC-005542
A protein that helps control several cell functions, including cell division and survival, and binds to rapamycin and other drugs. mTOR may be more active in some types of cancer cells than it is in normal cells. Blocking mTOR may cause the cancer cells to die. It is a type of serine/threonine protein kinase. Also called mammalian target of rapamycin and mechanistic target of rapamycin.
| Identifier | MLC-T-ONC-005542 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | mammalian target of rapamycin; mechanistic target of rapamycin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005542",
"term": "mTOR",
"field": "Oncology and biomedicine",
"definition": "A protein that helps control several cell functions, including cell division and survival, and binds to rapamycin and other drugs. mTOR may be more active in some types of cancer cells than it is in normal cells. Blocking mTOR may cause the cancer cells to die. It is a type of serine/threonine protein kinase. Also called mammalian target of rapamycin and mechanistic target of rapamycin.",
"expansions": [
"mammalian target of rapamycin",
"mechanistic target of rapamycin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mtor/"
}
Record 11,348 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.